NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Thanks DD!
Honestly, I was quite surprised myself to get such a clear confirmation about the DCVax-L application. At first, the MHRA board member gave the standard cautious reply, saying he couldn’t be more helpful — which is exactly what you'd expect from a regulator during an ongoing review. But then came that follow-up message, explicitly stating that DCVax-L is being processed as an innovative medicine and is not part of the backlogs or delays. That felt significant.

I don’t think this was random or accidental. With all the recent public attention — parliamentary questions from Sarah Owen, and even MHRA's own public meeting on March 18 where they tried to show they are managing things well — I get the sense they wanted to gently correct any public concerns without breaching confidentiality. No details on the outcome, of course, but just enough to signal that the process is on track and not stuck.

So no, I don’t think this was just chance — more likely, this was a carefully measured reassurance, in line with the current scrutiny MHRA is under. And maybe my email just hit the right note at the right time.